EDGAR Filing Documents for 0000885590-15-000053

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0000885590-15-000053

Filing Date

2015-06-24

Accepted

2015-06-24 16:27:05

Documents

Period of Report

2015-06-23

Document Format Files

Seq	Description	Document	Type	Size
1	PRIMARY DOCUMENT	primary_doc.html	4
1	PRIMARY DOCUMENT	primary_doc.xml	4	4420
	Complete submission text file	0000885590-15-000053.txt		5995

Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8

Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792

Valeant Pharmaceuticals International, Inc. (Issuer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL A8 H7L 4A8

Business Address

Type: 4 | Act: 34 | File No.: 001-14956 | Film No.: 15949435